• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, Feb. 6 Natco Pharma Ltd has acquired Newark Drugs, a retail pharmacy store based in Newark, New Jersey in the US. This is the third acquisition that the company has made since 2006, the first two being Nicks Drugs and SaveMart Drugs.

Newark Drugs had been acquired by K&C Pharmacy, a US-based general partnership firm, in which Natco has a 75 per cent stake.

Newark Drugs clocks around $5 million in annual sales. With its location adjacent to Nicks Drugs, Natco would target to achieve economics of scale. With the acquisition of Newark, its revenues from the US retail would aggregate to over $35 million in a full year, according to a release.

Natco was open to acquiring a few more stores in the US to strengthen its presence in that country’s retail market, the release added.

More Stories on : Overseas Investments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Meet on Competition Act highlights industry concerns

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line